Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Pertinence Invest

Investor type Micro VC


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 9
Average round size
The average size of a deal this fund participated in
Portfolio companies 9
Lead investments 1
Exits 2
Key employees 2

Areas of investment

  • Biotechnology
  • Medical
  • Wellness
  • Fitness
  • Beauty

The venture was found in Europe in France. The main office of represented VC is situated in the Villeurbanne.

Besides them, we counted 2 critical employees of this fund in our database.

The fund has no specific favorite in a number of founders of portfolio startups. For fund there is a match between the location of its establishment and the land of its numerous investments - France. Among the most popular portfolio startups of the fund, we may highlight Tilkee, Skinjay, Olikrom. Among the most successful fund investment fields, there are Business Intelligence, CRM. Moreover, a startup needs to be at the age of 1 and less years to get the investment from the fund.

Speaking about the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2015. The common things for fund are deals in the range of 100 thousands - 1 million dollars. The fund is constantly included in less than 2 investment rounds annually. Opposing the other organizations, this Pertinence Invest works on 4 percentage points less the average amount of lead investments.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Pertinence Invest, startups are often financed by Wilco. The meaningful sponsors for the fund in investment in the same round are KREAXI, Starquest Capital, Rhone-Alpes Creation. In the next rounds fund is usually obtained by KREAXI, Starquest Capital, Social Family Group.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Pertinence Invest:
Typical Co-investors
Pertinence Invest is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Pertinence Invest:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
42CAP Bayern, Germany, Munich
Arches Capital Chicago, Illinois, United States
Arena Alpha -
ARGO Group International Delaware, Newark, United States
Carnegie Stockholm, Stockholm County, Sweden
Givaudan Geneva, Geneve, Switzerland
GLG Partners England, London, United Kingdom
Huatsing Capital Management Co. Ltd. Beijing, Beijing, China
Hunt Energy Enterprises Dallas, Texas, United States
Mankekar Family Office -
NES Partners Copenhagen, Denmark, Hovedstaden
Qianhai Huaye Touzi China, Japan, Kagoshima Prefecture
Qingying Fund -
Scopely California, Culver City, United States
Tenfore Holdings New York, New York, United States
Texcel International -
TOM Group Limited China, Hong Kong, Hong Kong Island
Volvo Group Venture Capital Gothenburg, Sweden, Vastra Gotaland
Xinjiang Dongfan China, Ürümqi, Xinjiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Mablink Bioscience

$4M27 Apr 2021 Lyon, Rhone-Alpes, France


Consumer Goods
$849K03 Sep 2015 France, Ile-de-France


Environmental Engineering
Pollution Control
$1M13 Mar 2015 France, Auvergne-Rhône-Alpes, France


$354K25 Feb 2015 France, New Aquitaine


$118K01 Nov 2014 Nantes, Pays de la Loire, France


Business Intelligence
$590K12 Sep 2014 Lyon, Auvergne-Rhône-Alpes, France


Health Care
$708K30 Jun 2014 France, Auvergne-Rhône-Alpes, France


$436K20 Nov 2013 Pessac, Aquitaine, France

Freemens SAS

Information Technology
Renewable Energy
01 Jan 2013 France, Auvergne-Rhône-Alpes, France
Mablink Bioscience Raises €4M in Seed Funding

– Mablink Bioscience is a Lyon, France-based company developing antibody-drug conjugates (ADC).
– The company raised €4M in a seed financing round.
Elaia Partners led the round with participation from Pertinence Invest 2 (Sofimac Innovation advised by Mérieux Equity Partners), Sham Innovation Santé (advised by Turenne Capital), Fondation Fournier-Majoie, Simba Santé (Angelor) and Crédit Agricole Création.
– The new investment will be used to move forward its ADC pipeline.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Pertinence Invest?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: